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There are only few studies on pediatric epilepsy in geographic isolates, we investigated the frequency and 
characteristics of pediatric epilepsy in a typical geographic isolate, with a twofold purpose: 1. To calculate 
incidence and prevalence of the disease; 2. To investigate the genetic component through family history, 
medical history and gene mapping, to be obtained from probands and relatives. The total population of island 
of Ischia is 61,086, including 8,381 children and adolescents aged 0-14 years. Only children and adolescents 
aged 1 through 14 years in the calendar year 2017 were eligible for investigation. Epilepsy was diagnosed 
according to the International League Against Epilepsy’s classification. A total of 36 children and adolescents 
were found with confirmed epilepsy. There were 16 girls and 20 boys. Included were 18 patients with epilepsy 
due to structural/metabolic diseases and 18 patients with idiopathic epilepsy. Perinatal complications were 
the predominant cause in patients with structural/metabolic diseases. The prevalence was 4.3 per 1,000. Only 
one patient was diagnosed prior to 2004, leaving 35 incident cases. The incidence in general pediatric 
population, calculated during the 14- year period, was 33.5 per 100,000/year (29 in female pediatric 
population e 39,1 in male pediatric population). In contrast with other reports from geographic isolates, our 
findings do not confirm a higher than expected prevalence of epilepsy. The prevalence of active epilepsy in 
children in our study was even lower than in the Eolian islands that included in the diagnosis only patients with 
two or more unprovoked seizures. 
 
 
